UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 204

Sortiert nach

Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells

Cellular physiology and biochemistry, 2018-01, Vol.51 (4), p.1518-1532

2018

Volltextzugriff (PDF)

Clinical significance of estrogen receptor phosphorylation

Endocrine-related cancer, 2011-02, Vol.18 (1), p.R1-R14

2011

Volltextzugriff (PDF)

Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides

Nucleic acids research, 2009-07, Vol.37 (13), p.4518

2009

Volltextzugriff (PDF)

Paracrine Crosstalk between Fibroblasts and ER+ Breast Cancer Cells Creates an IL1β-Enriched Niche that Promotes Tumor Growth

iScience, 2019-09, Vol.19, p.388-401

2019

Volltextzugriff (PDF)

Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target

The Journal of steroid biochemistry and molecular biology, 2008-03, Vol.109 (1), p.1-10

2008

Volltextzugriff (PDF)

Is oestrogen receptor- β a predictor of endocrine therapy responsiveness in human breast cancer?

Endocrine-related cancer, 2006-06, Vol.13 (2), p.327-334

2006

Volltextzugriff (PDF)

A bi-faceted role of estrogen receptor β in breast cancer

Endocrine-related cancer, 2013-06, Vol.20 (3), p.R127-R139

2013

Volltextzugriff (PDF)

Reduced Expression of the Small Leucine-rich Proteoglycans, Lumican, and Decorin Is Associated with Poor Outcome in Node-negative Invasive Breast Cancer

Clinical cancer research, 2003-01, Vol.9 (1), p.207-214

2003

Volltextzugriff (PDF)

Influence of Evolution in Tumor Biobanking on the Interpretation of Translational Research

Cancer epidemiology, biomarkers & prevention, 2008-12, Vol.17 (12), p.3344-3350

2008

Volltextzugriff (PDF)

The role of estrogen receptor-β in breast cancer

Seminars in reproductive medicine, 2012-01, Vol.30 (1), p.5

2012

Volltextzugriff (PDF)

Activated Mitogen-activated Protein Kinase Expression during Human Breast Tumorigenesis and Breast Cancer Progression

Clinical cancer research, 2002-06, Vol.8 (6), p.1747-1753

2002

Volltextzugriff (PDF)

A phosphorylation code for oestrogen receptor-α predicts clinical outcome to endocrine therapy in breast cancer

Endocrine-related cancer, 2010-09, Vol.17 (3), p.589-597

2010

Volltextzugriff (PDF)

Recurrent copy number alterations in young women with breast cancer

Oncotarget, 2018-02, Vol.9 (14), p.11541-11558

2018

Volltextzugriff (PDF)

Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes

Cancer letters, 2016-08, Vol.378 (2), p.69-79

2016

Volltextzugriff (PDF)

Phospho-Serine-118 Estrogen Receptor-α Expression Is Associated with Better Disease Outcome in Women Treated with Tamoxifen

Clinical cancer research, 2004-09, Vol.10 (17), p.5902-5906

2004

Volltextzugriff (PDF)

The Prohibitins: emerging roles in diverse functions

Journal of cellular and molecular medicine, 2006-04, Vol.10 (2), p.353-363

2006

Volltextzugriff (PDF)

Assay Development for the Determination of Phosphorylation Stoichiometry Using Multiple Reaction Monitoring Methods with and without Phosphatase Treatment: Application to Breast Cancer Signaling Pathways

Analytical chemistry (Washington), 2010-07, Vol.82 (13), p.5610-5620

2010

Volltextzugriff (PDF)

Estrogen regulates luminal progenitor cell differentiation through H19 gene expression

Endocrine-related cancer, 2015-08, Vol.22 (4), p.505-517

2015

Volltextzugriff (PDF)

Intermittent Hypoxia Induces Proteasome-Dependent Down-Regulation of Estrogen Receptor α in Human Breast Carcinoma

Clinical cancer research, 2004-12, Vol.10 (24), p.8720-8727

2004

Volltextzugriff (PDF)

Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer

Endocrine-related cancer, 2012-04, Vol.19 (2), p.181-195

2012

Volltextzugriff (PDF)

The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer

Cancer research (Chicago, Ill.), 2005-07, Vol.65 (13), p.5696-5702

2005

Volltextzugriff (PDF)

Psoriasin (S100A7) Expression and Invasive Breast Cancer

The American journal of pathology, 1999-12, Vol.155 (6), p.2057-2066

1999

Volltextzugriff (PDF)

Psoriasin (S100A7) Expression Is Associated with Poor Outcome in Estrogen Receptor-negative Invasive Breast Cancer

Clinical cancer research, 2003-07, Vol.9 (7), p.2627-2631

2003

Volltextzugriff (PDF)

Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy

Molecular cancer therapeutics, 2014-07, Vol.13 (7), p.1882-1893

2014

Volltextzugriff (PDF)

Lumican and decorin are differentially expressed in human breast carcinoma

The Journal of pathology, 2000-11, Vol.192 (3), p.313-320

2000

Volltextzugriff (PDF)

1 – 25 von 204

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink (Online service)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(187)

Publikationsform

Sprache

Englisch
(204)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells

Clinical significance of estrogen receptor phosphorylation

Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides

Paracrine Crosstalk between Fibroblasts and ER+ Breast Cancer Cells Creates an IL1β-Enriched Niche that Promotes Tumor Growth

Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target

Is oestrogen receptor- β a predictor of endocrine therapy responsiveness in human breast cancer?

A bi-faceted role of estrogen receptor β in breast cancer

Reduced Expression of the Small Leucine-rich Proteoglycans, Lumican, and Decorin Is Associated with Poor Outcome in Node-negative Invasive Breast Cancer

Influence of Evolution in Tumor Biobanking on the Interpretation of Translational Research

The role of estrogen receptor-β in breast cancer

Activated Mitogen-activated Protein Kinase Expression during Human Breast Tumorigenesis and Breast Cancer Progression

A phosphorylation code for oestrogen receptor-α predicts clinical outcome to endocrine therapy in breast cancer

Recurrent copy number alterations in young women with breast cancer

Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes

Phospho-Serine-118 Estrogen Receptor-α Expression Is Associated with Better Disease Outcome in Women Treated with Tamoxifen

The Prohibitins: emerging roles in diverse functions

Assay Development for the Determination of Phosphorylation Stoichiometry Using Multiple Reaction Monitoring Methods with and without Phosphatase Treatment: Application to Breast Cancer Signaling Pathways

Estrogen regulates luminal progenitor cell differentiation through H19 gene expression

Intermittent Hypoxia Induces Proteasome-Dependent Down-Regulation of Estrogen Receptor α in Human Breast Carcinoma

Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer

The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer

Psoriasin (S100A7) Expression and Invasive Breast Cancer

Psoriasin (S100A7) Expression Is Associated with Poor Outcome in Estrogen Receptor-negative Invasive Breast Cancer

Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy

Lumican and decorin are differentially expressed in human breast carcinoma

Aktive Filter

Suchergebnisse filtern